Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.63 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25186523 | 0.91 | CYP3A4 (0.53) | CYP3A4SKP2TSHRPNMTTAAR1 | |
| SCHEMBL2747648 | 0.88 | SKP2 (0.65) | CYP3A4SKP2TSHRPNMTTAAR1 | |
| SCHEMBL1170188 | 0.87 | CYP3A4 (0.74) | CYP3A4SKP2TSHRPNMTTAAR1 | |
| SCHEMBL7774089 | 0.85 | SKP2 (0.56) | CYP3A4SKP2ALDH1A1GLASMN1; SMN2 | |
| SCHEMBL11205585 | 0.85 | SKP2 (0.56) | CYP3A4SKP2ALDH1A1GLASMN1; SMN2 | |
| SCHEMBL3788823 | 0.83 | TP53 (0.46) | CYP3A4SKP2TSHRPNMTTAAR1 | |
| SCHEMBL10584299 | 0.83 | CYP3A4 (0.68) | CYP3A4SKP2TSHRPNMTTAAR1 | |
| SCHEMBL3793211 | 0.83 | CYP3A4 (0.68) | CYP3A4SKP2TSHRPNMTTAAR1 | |
| SCHEMBL2735049 | 0.81 | TAAR1 (0.69) | CYP3A4TSHRPNMTTAAR1ALDH1A1 | |
| SCHEMBL5604961 | 0.80 | SKP2 (0.53) | CYP3A4SKP2TSHRALDH1A1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114163838-B | Supercritical CO 2 Yellow reactive disperse dye for dyeing and preparation method and application thereof | 大连工业大学 | 2023-05-16 | — | — | CN | disclosed |
| CN-107817649-B | Photosensitive resin composition, polyamide resin and method for producing same, compound and method for producing same, cured film and method for producing same | 东京应化工业株式会社 | 2022-09-16 | — | — | CN | disclosed |
| CN-114163838-A | Supercritical CO2Yellow reactive disperse dye for dyeing and preparation method and application thereof | 大连工业大学 | 2022-03-11 | — | — | CN | disclosed |
| CN-101379111-B | Polymerizable unsaturated compound and method for producing the same | WAKO PURE CHEM IND LTD | 2012-01-11 | — | — | CN | disclosed |
| US-7960567-B2 | Compounds and methods useful for treating asthma and allergic inflammation | AMGEN INC. (US) | 2011-06-14 | — | — | US | disclosed |
| CN-101868444-A | Acetylenic compound, salt thereof, condensate thereof, and composition thereof | FUJIFILM CORP | 2010-10-20 | — | — | CN | disclosed |
| CN-101808982-A | Acetylene compound | FUJIFILM CORP | 2010-08-18 | — | — | CN | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| CN-101379111-A | Polymerizable unsaturated compound and method for producing the same | WAKO PURE CHEM IND LTD (JP) | 2009-03-04 | — | — | CN | disclosed |
| US-20080312270-A1 | COMPOUNDS AND METHODS USEFUL FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION | AMGEN INC. | 2008-12-18 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| US-5081196-A | Containing an acetylenically unsaturated monoamine compound | UBE INDUSTRIES, LTD. (JP) | 1992-01-14 | — | — | US | disclosed |
| EP-0357367-A2 | Terminal-modified aromatic imide oligomer composition | UBE INDUSTRIES, LTD. (JP) | 1990-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312270-A1 | COMPOUNDS AND METHODS USEFUL FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION | CCL11, LTC4S, TSLP | CYP3A4 659/4885SKP2 3066/4885TSHR 4812/4885 |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | CYP3A4 177/4885SKP2 2544/4885TSHR 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.